Literature DB >> 15939159

Use of the genomic matching technique to complement multiplex STR profiling reduces DNA profiling costs in high volume crimes and intelligence led screens.

R Laird1, R L Dawkins, S Gaudieri.   

Abstract

The genomic matching technique (GMT) targets duplicated polymorphic sequences within genomic blocks in the human major histocompatibility complex (MHC), differentiating between individuals at the DNA level using a single primer pair per block. The GMT is currently used to supplement human leukocyte antigen (HLA) typing to match donor and recipient pairs for bone marrow transplantation and has the potential to be employed as a powerful exclusion tool in forensic biology. The GMT is highly reproducible, produces DNA profiles from less than 1 ng of DNA and was successfully employed to profile a range of forensic samples including buccal swabs, handled objects and fingerprints. Furthermore, GMT profiles from a single genomic block in the MHC are likely to be more discriminatory than known highly polymorphic short tandem repeat (STR) loci such as ACTBP2. As such, the GMT can reduce the cost of investigations that require profiling of multiple suspects or samples from one or more crime scenes and could be extended to profile genomic blocks in other polymorphic genetic systems in the human genome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939159     DOI: 10.1016/j.forsciint.2005.02.018

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Mannose binding lectin (MBL) copy number polymorphism in Zebrafish (D. rerio) and identification of haplotypes resistant to L. anguillarum.

Authors:  Andrew N Jackson; Craig A McLure; Roger L Dawkins; Peter J Keating
Journal:  Immunogenetics       Date:  2007-10-18       Impact factor: 2.846

2.  Epistasis between the MHC and the RCA alpha block in primary Sjögren syndrome.

Authors:  S Lester; C McLure; J Williamson; P Bardy; M Rischmueller; R L Dawkins
Journal:  Ann Rheum Dis       Date:  2007-09-18       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.